Pathology · Hematological Malignancies (Leukemias, Lymphomas, Myeloma)

In chronic myeloid leukemia (CML), the BCR-ABL1 fusion protein of the p210 isoform constitutively activates which downstream signaling pathway primarily responsible for anti-apoptotic survival?

  • A NOTCH pathway
  • B Hedgehog-GLI pathway
  • C PI3K-AKT-mTOR pathway
  • D TGF-beta-SMAD pathway
Correct answer: C. PI3K-AKT-mTOR pathway

Explanation

The BCR-ABL1 kinase in CML constitutively activates multiple downstream signaling cascades, but PI3K-AKT-mTOR is the primary pathway mediating anti-apoptotic survival signals by phosphorylating and inactivating pro-apoptotic factors such as BAD. RAS-MAPK (proliferation) and JAK-STAT (survival and differentiation) are also activated. The NOTCH, Hedgehog, and TGF-beta pathways are not direct downstream targets of BCR-ABL1.

Reference: Robbins & Cotran Pathologic Basis of Disease, 10th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Hematological Malignancies (Leukemias, Lymphomas, Myeloma) MCQs

See all Hematological Malignancies (Leukemias, Lymphomas, Myeloma) MCQs →